Skip to main content

Medical conditions and risk of adult myeloid leukemia

Abstract

Purpose

Although a few previous studies have reported positive associations between adult myeloid leukemia and a history of certain medical conditions, the etiology of most cases remains largely unknown. Our purpose was to examine associations between certain medical conditions and adult myeloid leukemia.

Methods

Using logistic regression, we evaluated associations between 16 self-reported medical conditions and myeloid leukemia in a case–control study of 670 cases [including 420 acute myeloid leukemia (AML) and 186 chronic myelogenous leukemia (CML)] and 701 population-based controls.

Results

We observed significant positive associations between AML and ulcerative colitis (odds ratio (OR) = 3.8; 95 % confidence interval (CI), 1.1–13) and between CML and peptic ulcer (OR = 2.0; 95% CI, 1.1–3.8). A personal cancer history increased both AML (OR = 2.6; 95% CI, 1.7–3.9) and CML (OR = 3.5; 95% CI, 2.0–5.8) risk even after excluding individuals who reported prior radiation and/or chemotherapy treatment.

Conclusion

Certain inflammatory medical conditions and a personal history of cancer, independent from therapy, are associated with an increased risk of myeloid leukemia.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA (2009) Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer 100(5):822–828

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    Karlen P, Lofberg R, Brostrom O, Leijonmarck CE, Hellers G, Persson PG (1999) Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol 94(4):1047–1052

    PubMed  CAS  Google Scholar 

  3. 3.

    Winther KV, Jess T, Langholz E, Munkholm P, Binder V (2004) Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2(12):1088–1095

    PubMed  Article  Google Scholar 

  4. 4.

    Askling J, Brandt L, Lapidus A, Karlen P, Bjorkholm M, Lofberg R et al (2005) Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 54(5):617–622

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Hemminki K, Li X, Sundquist J, Sundquist K (2008) Cancer risks in ulcerative colitis patients. Int J Cancer 123(6):1417–1421

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Kristinsson SY, Bjorkholm M, Hultcrantz M, Derolf AR, Landgren O, Goldin LR (2011) Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol 29(21):2897–2903

    PubMed  Article  Google Scholar 

  7. 7.

    Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A et al (2005) Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 64(10):1414–1420

    PubMed  Article  CAS  Google Scholar 

  8. 8.

    Ross JA, Blair CK, Cerhan JR, Soler JT, Hirsch BA, Roesler MA et al (2011) Nonsteroidal anti-inflammatory drug and acetaminophen use and risk of adult myeloid leukemia. Cancer Epidemiol Biomarkers Prev 20(8):1741–1750

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Slattery ML, Edwards SL, Caan BJ, Kerber RA, Potter JD (1995) Response rates among control subjects in case–control studies. Ann Epidemiol 5(3):245–249

    PubMed  Article  CAS  Google Scholar 

  10. 10.

    Das KK, Nishino HT, Chan AT (2010) Treatment-associated acute myeloid leukemia in a patient with Crohn’s disease on 6-mercaptopurine. Inflamm Bowel Dis 16(9):1454–1456

    PubMed  Article  Google Scholar 

  11. 11.

    Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, Bouvard V et al (2009) A review of human carcinogens-Part A: pharmaceuticals. Lancet Oncol 10(1):13–14

    PubMed  Article  Google Scholar 

  12. 12.

    Nguyen T, Vacek PM, O’Neill P, Colletti RB, Finette BA (2009) Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease. Cancer Res 69(17):7004–7012

    PubMed  Article  CAS  Google Scholar 

  13. 13.

    Schmiegelow K (2011) Epidemiology of therapy-related myeloid neoplasms after treatment for pediatric acute lymphoblastic leukemia in the nordic countries. Mediterr J Hematol Infect Dis 3(1):e2011020

    PubMed  Article  Google Scholar 

  14. 14.

    Fabry TL, Sachar DB, Janowitz HD (1980) Acute myelogenous leukemia in patients with ulcerative colitis. J Clin Gastroenterol 2(3):225–227

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Karaoglu AO, Kadikoylu G, Yukselen V, Yasa MH, Bolaman Z (2004) Gastrointestinal lesions and Helicobacter pylori in patients with myeloproliferative disorders. Saudi Med J 25(12):1913–1916

    PubMed  Google Scholar 

  16. 16.

    Grulich AE, Vajdic CM (2005) The epidemiology of non-Hodgkin lymphoma. Pathology 37(6):409–419

    PubMed  Article  Google Scholar 

  17. 17.

    Lehtinen M, Ogmundsdottir HM, Bloigu A, Hakulinen T, Hemminki E, Gudnadottir M et al (2005) Associations between three types of maternal bacterial infection and risk of leukemia in the offspring. Am J Epidemiol 162(7):662–667

    PubMed  Article  Google Scholar 

  18. 18.

    Schottenfeld D, Fraumeni JF (2006) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, Oxford

    Book  Google Scholar 

  19. 19.

    Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A et al (1994) Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat Res 137(2 Suppl):S68–S97

    PubMed  Article  CAS  Google Scholar 

  20. 20.

    Tsushima H, Iwanaga M, Miyazaki Y (2012) Late effect of Atomic bomb radiation on myeloid disorders: leukemia and myelodysplastic syndromes. Int J Hematol 95(3):232–238

    PubMed  Article  Google Scholar 

  21. 21.

    Howard RA, Gilbert ES, Chen BE, Hall P, Storm H, Pukkala E et al (2007) Leukemia following breast cancer: an international population-based study of 376,825 women. Breast Cancer Res Treat 105(3):359–368

    PubMed  Article  Google Scholar 

  22. 22.

    Wang KL, Lin LY, Chen PM, Lin HD (2005) Chronic myeloid leukemia after treatment with 131 for thyroid carcinoma. J Chin Med Assoc 68(5):230–233

    PubMed  Article  Google Scholar 

  23. 23.

    Bauduer F, Ducout L, Dastugue N, Marolleau JP (2002) Chronic myeloid leukemia as a secondary neoplasm after anti-cancer radiotherapy: a report of three cases and a brief review of the literature. Leuk Lymphoma 43(5):1057–1060

    PubMed  Google Scholar 

  24. 24.

    Tsuzuki M, Handa K, Yamamoto K, Hasegawa A, Yamamoto Y, Watanabe M et al (2008) Chronic myeloid leukemia following chemotherapy with 5′-deoxy-5-fluorouridine for gastric cancer. Intern Med 47(19):1739–1741

    PubMed  Article  Google Scholar 

  25. 25.

    Health Pm. Ulcerative Colitis. 2011 [cited 2011 11/4/2011]

  26. 26.

    Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126(6):1504–1517

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

The authors acknowledged the grants from NIH T32 CA099936, R25 CA047888, R01 CA107143, and K05 CA157439.

Conflict of interest

The authors have no financial disclosures to report.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Julie A. Ross.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Johnson, K.J., Blair, C.M., Fink, J.M. et al. Medical conditions and risk of adult myeloid leukemia. Cancer Causes Control 23, 1083–1089 (2012). https://doi.org/10.1007/s10552-012-9977-y

Download citation

Keywords

  • Acute myeloid leukemia
  • Chronic myeloid leukemia
  • Autoimmune disorders
  • Medical conditions